Showing results (11-20 of 80) with videos related to
Sort By:
Pageof 8
Vaccine|November 2, 2007
Cell based cancer vaccines: regulatory and commercial developmentJohn Copier, Stephen Ward, Angus DalgleishAnticancer Research|October 3, 2018
Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic CannabidiolJulian Kenyon, Wai Liu, Angus DalgleishImmunological Reviews|February 26, 2011
Infection, immunoregulation, and cancerGraham A W Rook, Angus DalgleishMolecular Diagnosis & Therapy|December 13, 2006
Biomarkers for the development of cancer vaccines: current statusJohn Copier, Mike Whelan, Angus DalgleishCurrent Opinion in Drug Discovery & Development|February 20, 2008
Technical challenges facing therapeutic cancer vaccinesStephen Ward, John Copier, Angus DalgleishImmunotherapy|April 6, 2011
Current status and future applications of cellular therapies for cancerJohn Copier, Mark Bodman-Smith, Angus DalgleishF1000Prime Reports|July 4, 2014
Developments in HIV-1 immunotherapy and therapeutic vaccinationPeter Lawrence Smith, Helen Tanner, Angus DalgleishExpert Review of Anticancer Therapy|April 27, 2013
Revisiting the role of systemic therapies in patients with metastatic melanoma to the CNSDionysis Papadatos-Pastos, Adam Januszewski, Angus DalgleishJournal of Immunological Methods|December 31, 2002
Cryopreservation of immature monocyte-derived dendritic cells results in enhanced cell maturation but reduced endocytic activity and efficiency of adenoviral transductionJustin John, James Hutchinson, Angus Dalgleish, et al.Drug Discovery Today|March 8, 2003
Cancer immunotherapy: an embarrassment of riches?Mike Whelan, Joseph Whelan, Nick Russell, et al.Pageof 8